Merck & Co Inc (MRK)

Pharmaceuticals

MRK · NEW YORK STOCK EXCHANGE, INC. · USD

New to investing? How to read this page →

$125.99

−2.23%

Watch Compare

Price · 1 year

Watch + Add to portfolio

Loading live analysis…

Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS

$7.28

ROE

18.9%

Gross margin

76.7%

Debt/Equity

1.07x

Revenue growth

4.9%

Merck & Co Inc — company intelligence

Earnings surprises

Q1 2026$-1.28 vs $-1.52 est+16.0%

Q4 2025$2.09 vs $2.03 est+3.0%

Q3 2025$2.68 vs $2.37 est+13.1%

Q2 2025$2.19 vs $2.03 est+7.7%

Analyst consensus · 36 analysts

25 Buy11 Hold0 Sell

Updated Jul 8, 2026

Insider activity · 90 days

37 buys15 sellsnet +651,491 shares

Craig Pamela J.Buy 1,853 · May 29, 2026

THULIN INGE GBuy 1,853 · May 29, 2026

Seidman Christine EBuy 1,853 · May 29, 2026

Recent SEC filings

4 — Insider transaction reportJul 1, 2026

Latest news

Merck (MRK) Stock Sinks As Market Gains: Here's Why — Yahoo · 13h ago

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC) — Yahoo · 16h ago

This Blue-Chip Dividend Stock Is Outperforming the S&P 500 in 2026 — Yahoo · 1d ago

EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth? — Yahoo · 1d ago

Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers — Yahoo · 1d ago

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen Stocks Learn Intrinsic Value Trading Signals Compare Stocks

Explore more

More in Pharmaceuticals →More in Drug Manufacturers - General →Stocks in US →Stocks on NEW YORK STOCK EXCHANGE, INC. →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

Novo Nordisk A/SNVO Eli Lilly and CoLLY Johnson & JohnsonJNJ AstraZeneca PLCAZN Pfizer, Inc.PFE Bristol-Myers Squibb CompanyBMY

About Merck & Co Inc

Weekly undervalued picks (like MRK)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.